Jason Mckeown
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Randomized, Double Blind, Sham-Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Generalized Anxiety Disorder.
Journal: Clinical EEG and neuroscience
Published: March 25, 2025
A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder.
Journal: Journal of affective disorders
Published: March 03, 2025
Non-invasive vestibular nerve stimulation (VeNS) reduces visceral adipose tissue: results of a randomised controlled trial.
Journal: Scientific reports
Published: October 04, 2024
Anxiolytic effects of vestibular stimulation: an update.
Journal: Journal of basic and clinical physiology and pharmacology
Published: February 01, 2023
Electrical vestibular nerve stimulation (VeNS): a follow-up safety assessment of long-term usage.
Journal: Journal of basic and clinical physiology and pharmacology
Published: December 22, 2021
Electrical vestibular nerve stimulation as an adjunctive therapy in the management of type 2 diabetes.
Journal: Journal of basic and clinical physiology and pharmacology
Published: July 18, 2020
Modulation of sleep using electrical vestibular nerve stimulation prior to sleep onset: a pilot study.
Journal: Journal of basic and clinical physiology and pharmacology
Published: February 09, 2020
Anti-diabetic effect of vestibular stimulation is mediated via AMP-activated protein kinase.
Journal: Medical hypotheses
Published: January 12, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026